sur Viromed Medical AG (isin : DE000A3MQR65)
Prof. Dr. Michael A. Rübhausen Joins Viromed Medical AG's Advisory Board
Viromed Medical AG has announced Prof. Dr. Michael A. Rübhausen's appointment to its Medical Advisory Board, effective immediately. This addition is expected to bolster the company's scientific evaluation capabilities at the nexus of material properties, spectroscopy, and cold plasma research.
Rübhausen leads the Optics Working Group at the Universität Hamburg and serves as the Managing Director. His prolific research covers modern spectroscopic methods applied in studying superconductors and quantum materials. His work is extensively published, with over 180 publications and roughly 4,000 citations in noted journals like Nature Communications.
The strategic move by Viromed, a medical technology firm and a pioneer in cold plasma applications, aims to harness his expertise to advance research and support their technological objectives, particularly in material properties and cold plasma intersection.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Viromed Medical AG